Abstract
Introduction Intracerebral hemorrhage (ICH) is the second most common cause of stroke and remains the second leading cause of disability impacting underserved areas. Since 2015, there has been a paradigm shift in managing ischemic stroke through applying AI and ML. However, ICH patients lack such protocol.
Objective To create a rapid, cloud-based, and deployable ML method to detect ICH potentially across the Mayo Clinic enterprise then expand to involve underserved areas.
Methods We utilized RSNA dataset for ICH. We made four total iterations using Google Cloud Vertex AutoML. We trained an AutoML model with 2,000 images followed by 6,000 images from both ICH positive and negative classes. Pixel values were measured by the Hounsfield units presenting a width of 80 Hounsfield and a level of 40 Hounsfield as the bone window. This was followed by a more detailed image preprocessing approach by combining the pixel values from each of the brain, subdural, and soft tissue window-based grayscale images into R(red)G(green)B(blue)-channel images to boost the binary ICH classification performance. Four experiments with AutoML were applied to study the impacts of training sample size and image preprocessing on model performance.
Results Out of the four AutoML experiments, the best-performing model achieved a 95.8% average precision, 91.4% precision, and 91.4% recall. Based on this analysis, our binary ICH classifier HEADS UP is both accurate and performant.
Conclusion HEADS UP, is a rapid, cloud-based, deployable ML method to detect ICH. This tool can help expedite the care of patients with ICH in resource-limited hospitals.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
